01
Cash & equivalents increased 446.9%
Cash & equivalents changed +446.9% from the comparable as-filed period.
$25.3M→$138.3MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTSELLAS Life Sciences Group, Inc.'s latest supported as-filed period reports revenue of $0. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +446.9% from the comparable as-filed period.
Net income changed -45.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -54.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
SLS · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001390478-26-000013SEC ↗10-QAug 11, 2026Period Jun 30, 20260001390478-26-000012SEC ↗8-KJul 27, 2026Period Jul 24, 20260001104659-26-087110SEC ↗8-KJun 25, 2026Period Jun 24, 20260001104659-26-077556SEC ↗8-KJun 18, 2026Period Jun 16, 20260001104659-26-075775SEC ↗4Jun 18, 2026Period Jun 16, 20260001104659-26-075773SEC ↗8-KJun 2, 2026Period Jun 2, 20260001104659-26-069251SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jun 16, 2026Filed Jun 18, 2026 | Stergiou Angelos M.President and CEO | Grant Or AwardDirect | 1,065,000 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Stock-based compensation changed +102.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001390478-26-000009